AbCellera prices oversubscribed offering at $9.75 a share to raise $200 million

Reuters2026/08/13 04:10

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

AbCellera priced an oversubscribed underwritten public offering expected to raise about USD 200 million in gross proceeds.
Deal includes 17,435,897 common shares priced at USD 9.75 per share.
Also issued pre-funded warrants for up to 3,076,926 common shares priced at USD 9.75 each, with a USD 0.00001 exercise price.
Closing is expected on Aug. 14, 2026, subject to customary conditions.
Proceeds earmarked for internal pipeline R&D, including lead clinical program ABCL635, working capital, general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abcellera Biologics Inc. published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

AbCellera prices oversubscribed offering at $9.75 a share to raise $200 million

You may also like

Crypto prices